IBI Faculty Member Shows How Genetic Variation Can Influence Anti-Diabetic Drug Response

IBI faculty member Mitchell Lazar, M.D., Ph.D., and colleagues published a paper in Cell showing how single-nucleotide polymorphisms (SNPs) can influence anti-diabetic drug response. This work has important implications for the development of precision medicine strategies for common diseases such as type 2 diabetes. For more information see the Penn Medicine press release.